These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 21795772

  • 1. Magnetic nanoparticle biodistribution following intratumoral administration.
    Giustini AJ, Ivkov R, Hoopes PJ.
    Nanotechnology; 2011 Aug 26; 22(34):345101. PubMed ID: 21795772
    [Abstract] [Full Text] [Related]

  • 2. An in vivo transmission electron microscopy study of injected dextran-coated iron-oxide nanoparticle location in murine breast adenocarcinoma tumors versus time.
    Giustini AJ, Ivkov R, Hoopes PJ.
    Proc SPIE Int Soc Opt Eng; 2009 Feb 12; 7181():71810M. PubMed ID: 25301988
    [Abstract] [Full Text] [Related]

  • 3. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
    Dan M, Bae Y, Pittman TA, Yokel RA.
    Pharm Res; 2015 May 12; 32(5):1615-25. PubMed ID: 25377069
    [Abstract] [Full Text] [Related]

  • 4. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
    Hoopes P, Tate J, Ogden J, Strawbridge R, Fiering S, Petryk A, Cassim S, Giustini A, Demidenko E, Ivkov R, Barry S, Chinn P, Foreman A.
    Proc SPIE Int Soc Opt Eng; 2009 Feb 23; 7181():71810P. PubMed ID: 25346583
    [Abstract] [Full Text] [Related]

  • 5. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
    Petryk A, Giustini A, Ryan P, Strawbridge R, Hoopes P.
    Proc SPIE Int Soc Opt Eng; 2009 Feb 23; 7181():71810N. PubMed ID: 25346581
    [Abstract] [Full Text] [Related]

  • 6. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
    Deh K, Zaman M, Vedvyas Y, Liu Z, Gillen KM, O' Malley P, Bedretdinova D, Nguyen T, Lee R, Spincemaille P, Kim J, Wang Y, Jin MM.
    Sci Rep; 2020 Jan 24; 10(1):1171. PubMed ID: 31980695
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
    Mojica Pisciotti ML, Lima E, Vasquez Mansilla M, Tognoli VE, Troiani HE, Pasa AA, Creczynski-Pasa TB, Silva AH, Gurman P, Colombo L, Goya GF, Lamagna A, Zysler RD.
    J Biomed Mater Res B Appl Biomater; 2014 May 24; 102(4):860-8. PubMed ID: 24458920
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.
    Hoopes P, Strawbridge R, Gibson U, Zeng Q, Pierce Z, Savellano M, Tate J, Ogden J, Baker I, Ivkov R, Foreman A.
    Proc SPIE Int Soc Opt Eng; 2007 Feb 13; 6440():64400K. PubMed ID: 25301985
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats.
    Hannon G, Bogdanska A, Keogh A, Finn SP, Gobbo OL, Prina-Mello A.
    Nanotoxicology; 2023 Dec 13; 17(8-9):562-580. PubMed ID: 37982374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K, Sano K, Makino A, Shimizu Y, Yamauchi F, Ogawa S, Ding N, Yano T, Temma T, Ono M, Saji H.
    Nanomedicine; 2015 Nov 13; 11(8):2051-60. PubMed ID: 26238078
    [Abstract] [Full Text] [Related]

  • 17. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.
    Salimi M, Sarkar S, Fathi S, Alizadeh AM, Saber R, Moradi F, Delavari H.
    Int J Nanomedicine; 2018 Nov 13; 13():1483-1493. PubMed ID: 29559777
    [Abstract] [Full Text] [Related]

  • 18. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
    Aboushoushah S, Alshammari W, Darwesh R, Elbaily N.
    Life Sci; 2021 Jul 15; 277():119625. PubMed ID: 34015288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.